**Core tip:** Forty-eight patients undergoing laparoscopic hepatectomy were randomly divided into a combined group (parecoxib combined with ropivacaine) and a control group. A visual analogue scale at rest and during movement was used to compare the analgesic effect of the two groups. Preoperative intravenous injection of parecoxib combined with the long-acting local anesthetic ropivacaine for incision infiltration is a simple and effective method for postoperative analgesia in patients undergoing laparoscopic hepatectomy, which could relieve postoperative pain and promote postoperative recovery.

INTRODUCTION
============

Since the first laparoscopic hepatectomy was reported in 1991, this minimally invasive surgery has been introduced into the field of liver surgery\[[@B1]\]. With the advances of technology in more than 20 years and the improvement of surgical experience and new operative equipment, laparoscopic hepatectomy has gradually replaced open hepatectomy with incomparable advantages. Patients can quickly recover to normal function with minimal abdominal wall injury\[[@B2],[@B3]\]. Nevertheless, the persistent pain due to the laparoscopy itself and the postoperative trauma affect the recovery of patients, prolong the hospital stay, and cause stress reactions and related complications, including cardiovascular and cerebrovascular accidents as well as gastrointestinal and neuroendocrine dysfunction\[[@B4],[@B5]\].

Currently, there is no uniform standard for analgesia during laparoscopic hepatectomy. Most of the analgesia schemes adopt epidural analgesia after laparotomy. Although the analgesia is effective, it has a great impact on the recovery of patients after laparoscopic hepatectomy and is not completely suitable for analgesia after laparoscopic hepatectomy\[[@B6]\]. Recently, it has been reported that local wound infiltration with ropivacaine in open hepatectomy can significantly reduce postoperative pain and the stress response and accelerate postoperative recovery\[[@B7]\]. Preoperative intravenous use of parecoxib plays an important role in preemptive analgesia by inhibiting the expression of COX-2 and the synthesis of prostaglandins in the central nervous system\[[@B8]\]. Although multimodal perioperative analgesia can significantly relieve postoperative pain, there is no relevant study of parecoxib combined with ropivacaine for post-laparoscopic hepatectomy analgesia.

Therefore, this study aimed to observe the analgesic effect of preoperative intravenous injection of the highly selective COX-2 inhibitor parecoxib combined with the long-acting local anesthetic ropivacaine for incision infiltration in patients undergoing laparoscopic hepatectomy.

MATERIALS AND METHODS
=====================

Clinical data
-------------

Forty-eight consecutive patients who underwent laparoscopic hepatectomy from January 2016 to December 2018 were included. The inclusion criteria included grades I--III according to the American Society of Anesthesiologists Physical Status Classification System (ASA), no history of motion sickness, nausea and vomiting, and chronic pain. Patients with gastroduodenal ulcer or coagulation dysfunction, or patients who were taking analgesics before operation were excluded from the study. This study was approved by the local Hospital Ethics Committee. Informed consent was obtained from all patients. The patients were randomly divided into two groups according to different analgesic methods: Combined group (parecoxib with ropivacaine, *n* = 24) and control group (*n* = 24). The specific clinical data of the patients are shown in Table [1](#T1){ref-type="table"}.

###### 

Demographic characteristics of the combined group and control group

  **Characteristic**               **Combined group**   **Control group**   ***t/χ***^2^ **value**   ***P*-value**
  -------------------------------- -------------------- ------------------- ------------------------ ---------------
  Age (yr)                         48.958 ± 12.685      50.208 ± 9.86       -0.381                   0.705
  Gender                                                                                             
  Male/Female                      10/14                15/9                2.087                    0.149
  Body weight (kg)                 68.368 ± 9.738       64.451 ± 8.652      1.473                    0.148
  ASA grade                                                                 0.543                    0.762
  I/II/III                         4/15/5               6/13/5                                       
  Incision length (cm)             8.194 ± 0.415        7.992 ± 0.422       1.674                    0.101
  Operative time                   136.083 ± 11.836     135.833 ± 11.484    0.074                    0.941
  Intraoperative bleeding volume   81.716 ± 14.737      79.116 ± 14.575     0.615                    0.542
  Maximum diameter of tumors       12.641 ± 5.075       10.705 ± 4.816      1.356                    0.182

ASA: American Society of Anesthesiologists.

Surgical procedure and analgesic methods
----------------------------------------

Preoperative Child-Pugh grade of liver function in both groups was grade A, and tracheal intubation plus combined intravenous inhalation was used. The combined group and the control group were given 20 mg of parecoxib or the same amount of saline intravenously 20 min before induction of anesthesia. Laparoscopic hepatectomy was performed by the same surgical team. Four to 5 puncture holes were assigned in the abdomen wall according to the location of the resected liver and the Joel-Cohen incision was used to take the specimen in which the length depended on the size of the specimen. In the combined group, 7.5 mg/mL ropivacaine solution was used for puncture incision infiltration, while in the control group, isotonic saline solution was used. When the abdominal puncture and Joel-Cohen incision were closed at the end of the operation, the subcutaneous tissue and deep myofascial and parietal peritoneum were infiltrated with a 20 mL solution. In addition, one or two abdominal drainage tubes were routinely placed near the hepatic section surface and fixed on the abdominal skin. Local infiltration of ropivacaine or saline was also given around the drainage tube.

All patients were given patient-controlled analgesia (PCA) to relieve pain after operation. Two hundred milliliters of 1 μg/mL of sufentanil was used in the analgesic pump. The flow rate of the pump was 2 mL/h with a bolus of 0.5 mL and 15 min of locking time. At the end of the operation, the PCA pump was inserted into the intravenous infusion tube. Sufentanil was routinely removed 48 h after the operation, and its cumulative use was recorded.

Observation indexes
-------------------

The visual analogue scale (VAS) was used to compare the analgesic effects of the two groups. The VAS scores were recorded at 0, 6, 12, 24, 36 and 48 h after the operation by those who did not know the grouping. The cumulative sufentanil, the recovery time for enterokinesia, the length of postoperative hospital stay, and the adverse reactions (nausea and vomiting) were recorded and compared between the two groups.

Statistical analysis
--------------------

Statistical analyses were performed with SPSS 20.0 (SPSS Inc., Chicago, IL, United States). The measurement data are expressed as the mean ± SD. The *t*-test was used to compare the measurement data between the two groups, and the *χ*^2^ test was used to calculate the counting data. *P* \< 0.05 was considered statistically significant.

RESULTS
=======

Comparison of clinical data between the two groups
--------------------------------------------------

All the operations were successfully completed, and all the patients recovered smoothly. Liver function recovered to normal status after the operation and all patients were discharged uneventfully. No complications such as bleeding or bile leakage occurred. The total incision length of the combined group was 8.194 ± 0.415 cm, while that of the control group was 7.992 ± 0.422 cm (*P* = 0.101). The operative times in the combined group and control group were 136.083 ± 11.836 min and 135.833 ± 11.484 min, respectively (*P* = 0.941). There were also no significant differences in age, gender, body weight, ASA grade, intraoperative bleeding, or maximum diameter of tumors between the two groups (Table [1](#T1){ref-type="table"}).

Comparison of analgesic effect between the two groups
-----------------------------------------------------

The change tendency of VAS scores of the combined group and the control group were similar after operation. The VAS scores increased gradually, peaked at 24 h, and then decreased. At rest, the VAS scores of the combined group were significantly lower than those of the control group at 0, 6, 12, 24, and 36 h, while the VAS scores of the two groups had no significant difference at 48 h (Figure [1A](#F1){ref-type="fig"}). On movement, the VAS scores of the combined group were significantly lower than those of the control group at 0, 6, 12, and 24 h. The VAS score of the two groups had no significant difference at 36 and 48 h (Figure [1B](#F1){ref-type="fig"}). This indicated that the combination of parecoxib and ropivacaine could help patients get out of bed early and reduce their pain experience (Table [2](#T2){ref-type="table"}).

![Visual analogue scale scores. A: Visual analogue scale (VAS) scores at rest during the first 48 h after surgery; B: VAS scores on movement during the first 48 h after surgery. VAS: Visual analogue scale.](WJCC-7-2704-g001){#F1}

###### 

Visual analogue scale scores at rest and during movement, and cumulative sufentanil in the combined group and control group

  **Characteristic**           **0 h**         **6 h**          **12 h**         **24 h**         **36 h**         **48 h**
  ---------------------------- --------------- ---------------- ---------------- ---------------- ---------------- ---------------
  VAS score at rest                                                                                                
  Combined group               2.421 ± 0.568   2.24 ± 0.394     2.064 ± 0.215    1.984 ± 0.379    1.967 ± 0.152    1.997 ± 0.095
  Control group                2.853 ± 0.566   2.619 ± 0.373    2.448 ± 0.24     2.233±0.353      2.398 ± 0.163    1.957 ± 0.108
  *t*                          -2.636          -3.427           -5.824           -2.353           -9.456           1.349
  *P*-value                    0.011           0.001            \< 0.001         0.023            \< 0.001         0.184
  VAS score during movement                                                                                        
  Combined group               3.281 ± 0.451   3.375 ± 0.816    3.359 ± 0.492    3.176 ± 0.461    3.033 ± 0.538    2.967 ± 0.257
  Control group                3.715 ± 0.41    3.49 ± 0.695     3.754 ± 0.614    3.764 ± 0.617    3.033 ± 0.61     3.061 ± 0.24
  *t*                          -3.491          -2.228           -2.46            -3.738           -0.003           -1.301
  *P*-value                    0.001           0.037            0.018            0.001            0.998            0.2
  Cumulative sufentanil (μg)                                                                                       
  Combined group               \-              15.731 ± 2.472   30.315 ± 4.015   44.339 ± 6.361   60.661 ± 3.773   88.13 ± 7.49
  Control group                \-              15.288 ± 2.072   30.085 ± 5.884   50.408 ± 6.056   70.325 ± 5.423   94.01 ± 8.329
  *t*                          \-              0.673            0.159            -3.385           -7.166           -2.572
  *P*-value                    \-              0.504            0.875            0.001            \< 0.001         0.013

VAS: Visual analogue scale.

Comparison of postoperative recovery between the two groups
-----------------------------------------------------------

The recovery time for enterokinesia in the combined group was 2.944 ± 0.896 d, which was significantly shorter than that in the control group (*P* \< 0.001). Similarly, the length of hospital stay in the combined group was significantly shorter than that in the control group (*P* = 0.001). All these suggested that the combination of parecoxib and ropivacaine can promote the recovery of patients after operation (Table [3](#T3){ref-type="table"}).

###### 

Recovery time for enterokinesia, postoperative nausea and vomiting, and hospital stay of the two groups

  **Characteristic**                    **Combined group**   **Control group**   ***t***   ***P*-value**
  ------------------------------------- -------------------- ------------------- --------- ---------------
  Recovery time for enterokinesia (d)   2.944 ± 0.896        3.954 ± 0.944       -3.804    \< 0.001
  PONA                                                                           0.3345    0.8460
  No PONA                               13                   11                            
  Nausea without vomiting               6                    7                             
  Nausea with vomiting                  5                    6                             
  Hospital stay (d)                     8.625 ± 2.505        11.986 ± 3.908      -3.548    0.001

PONA: Postoperative nausea and vomiting.

Comparison of cumulative sufentanil between the two groups
----------------------------------------------------------

Sufentanil at 1 μg/mL was delivered with an analgesic pump and any uncomfortable syndromes were monitored and recorded immediately. There was no significant difference in cumulative sufentanil at 6 and 12 h after operation, but there was a significant difference at 24, 36, and 48 h, especially at 24 and 36 h (Table [1](#T1){ref-type="table"}, Figure [2](#F2){ref-type="fig"}). However, there was no significant difference in postoperative complications such as nausea and vomiting between the two groups (Table [3](#T3){ref-type="table"}).

![Cumulative sufentanil during the first 48 h after surgery.](WJCC-7-2704-g002){#F2}

DISCUSSION
==========

Since its inception in the 1990s, more than 3000 patients worldwide have undergone laparoscopic hepatectomy\[[@B9]\].Compared with the traditional open hepatectomy, the advantages are less bleeding, incision, and pain, faster recovery of gastrointestinal function, and shorter hospital stay\[[@B10],[@B11]\]. Nevertheless, some patients after operation still suffer from visceral pain, wound prickling, shoulder pain, diaphragmatic abdominal pain, and other discomforts due to the visceral and incision trauma, carbon dioxide stimulation of abdominal visceral nerve and somatic nerve, intraoperative diaphragm traction, and other adverse factors\[[@B4],[@B5]\]. Insufficient postoperative analgesia can affect the early mobilization, delay intestinal function recovery, prolong recovery time and hospital stays, delay wound healing, and increase the risk of venous thromboembolism. Conversely, effective analgesia after operation is particularly important for patients to promote the recovery of gastrointestinal function, reduce complications, and shorten the length of hospital stay. It is an important part of accelerated rehabilitation surgery\[[@B12]\].

Preemptive analgesia refers to taking certain measures to block the noxious stimulation and to reduce the sensitivity of the central nervous system and peripheral nervous system to these stimulations in order to relieve pain or postoperative analgesia, make the analgesic effect more obvious, and reduce the dosage of analgesics\[[@B13],[@B14]\]. When the body tissues are traumatized, inflammatory mediators will be released. Prostaglandins are made through the conversion of arachidonic acid catalyzed by COX-2, which can directly lead to pain, increase the permeability of blood vessels, dilate blood vessels, create edema tissue, increase the sensitivity of effector receptors, and decrease the pain threshold, leading to peripheral hyperalgesia\[[@B15]\]. With the highly selective inhibitory action on COX-2, parecoxib blocks the synthesis of prostaglandins in peripheral and central regions, increases the pain threshold, inhibits hypersensitivity of pain threshold, and produces anti-inflammatory and analgesic effects. It has been reported recently that parecoxib has a good analgesic effect in laparoscopic hepatectomy\[[@B16]\]. However, parecoxib used in the above study was given after surgery. In our study, parecoxib was used 20 min before anesthesia induction. This not only achieved preemptive analgesic effects but also reduced the dosage of parecoxib, alleviating the side effects of medication to some extent.

Incision infiltration anesthesia is an effective and important component of multimodal postoperative analgesics, which is used in many types of surgery, including lumbar surgery, breast surgery, and inguinal hernia repair\[[@B17]-[@B19]\]. Local anesthetics used at the edge of the incision can block the influx of abdominal pain, reduce the sensitivity of spinal dorsal horn neurons, and provide an analgesic effect by inhibiting the spread of harmful impulses in the incision\[[@B20]\]. In addition, local anesthetics can inhibit local inflammation and pain receptor conduction and sensitivity in wound injury\[[@B21]\]. Ropivacaine, as a long-acting amide local anesthetic, is widely used in local anesthesia and postoperative analgesia. Its lipophilic reduction is related to the reduction of central nervous system toxicity and the incidence of cardiac toxicity\[[@B22]\]. Postoperative pain comes from the superficial structure of abdominal pain and peritoneal muscle and fascia structure, so local infiltration of ropivacaine can achieve long-term local analgesia. In this study, preoperative analgesia with parecoxib and local infiltration anesthesia with ropivacaine after operation were applied. The results showed that the combination of parecoxib and ropivacaine could effectively reduce the pain at rest and during movement after operation and promote the postoperative recovery, allowing for early discharge from the hospital. Moreover, in this study, using the Joel-Cohen incision could avoid transecting the abdominal muscles. This incision minimized the pain stimuli and considered the cosmetic results.

Opioids are commonly used intravenously for postoperative analgesia. Long-term use has potential addiction risks and serious side effects such as nausea, vomiting, constipation, respiratory depression, excessive sedation, and liver dysfunction\[[@B23]\]. Therefore, reducing the dosage and usage time of opioids is an appropriate way to avoid potential serious side effects. Our study showed that the cumulative sufentanil in the combined group decreased significantly. Meanwhile, the recovery time for enterokinesia in the combined group was shorter than that in the control group. This may be related to sufentanil inhibiting intestinal motility by binding to μ-2 and κ receptors in the intestine\[[@B24]\].

The sample size of this study is relatively small and needs to be included in future studies to further confirm the results of this study. In conclusion, preoperative intravenous injection of parecoxib combined with the long-acting local anesthetic ropivacaine for incision infiltration is a simple and effective method of postoperative analgesia to relieve postoperative pain and promote postoperative recovery after laparoscopic hepatectomy.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

The analgesic effect of the preoperative intravenous injection of parecoxib combined with long-acting local anesthetic ropivacaine for incision infiltration in patients undergoing laparoscopic hepatectomy is still unknown.

Research motivation
-------------------

Analgesic effect of parecoxib combined with ropivacaine in patients undergoing laparoscopic hepatectomy may be promising.

Research objectives
-------------------

To study the analgesic effect of the preoperative intravenous injection of parecoxib combined with long-acting local anesthetic ropivacaine for incision infiltration in laparoscopic hepatectomy patients.

Research methods
----------------

Laparoscopic hepatectomy patients were randomly divided into a combined group (parecoxib combined with ropivacaine) and a control group. The visual analogue scale (VAS) at rest and during movement was used to compare the analgesic effect of the two groups. The cumulative sufentanil, the recovery time for enterokinesia, the length of postoperative hospital stay, and the adverse reactions were recorded and compared between the two groups.

Research results
----------------

The VAS scores of the combined group were significantly lower than those of the control group. The recovery time for enterokinesia in the combined group was significantly shorter than that in the control group. The cumulative sufentanil in the combined group decreased significantly at 24, 36, and 48 h after operation.

Research conclusions
--------------------

Preoperative intravenous injection of parecoxib combined with the long-acting local anesthetic ropivacaine for incision infiltration is a simple and effective method for postoperative analgesia in laparoscopic hepatectomy patients. And it could relieve postoperative pain and promote postoperative recovery.

Research perspectives
---------------------

Injection of parecoxib combined with the long-acting local anesthetic ropivacaine for incision infiltration is useful for hepatectomy recovery.
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